Krause; Friedemann

Patent Applications and Registrations

Patent applications and USPTO patent grants for Krause; Friedemann.The latest application filed is for "computerized method and laboratory equipment for fast detection of failure in laboratory equipment".

Company Profile

1.4.12

Krause; Friedemann - Penzberg DE
Krause; Friedemann - Feldafing DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of identifying an individual to be treated by chemotherapy based on cytokeratin-19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) marker molecules and related uses Grant 11,402,381 - Krause , et al. August 2, 2	2022-08-02
Computerized Method And Laboratory Equipment For Fast Detection Of Failure In Laboratory Equipment App 20220099690 - Krause; Friedemann ; et al.	2022-03-31
Biomarkers In The Selection Of Therapy Of Heart Failure App 20220034910 - ZAUGG; Christian ; et al.	2022-02-03
Methods Of Detecting A Relapse Of A Lung Adenocarcinoma Based On Marker Human Epididymis Protein 4 (he4) And Related Uses App 20180292410 - Dayyani; Farshid ; et al.	2018-10-11
Biomarkers In The Selection Of Therapy Of Heart Failure App 20150268251 - Zaugg; Christian ; et al.	2015-09-24
Use Of Protein S100a12 As A Marker For Colorectal Cancer App 20150192587 - Wild; Norbert ; et al.	2015-07-09
Blood Plasma Biomarkers For Bevacizumab Combination Therapies For Treatment Of Pancreatic Cancer App 20140302019 - DELMAR; Paul ; et al.	2014-10-09
Blood Plasma Biomarkers For Bevacizumab Combination Therapies For Treatment Of Pancreatic Cancer App 20130195857 - DELMAR; Paul ; et al.	2013-08-01
Blood Plasma Biomarkers For Bevacizumab Combination Therapies For Treatment Of Pancreatic Cancer App 20130183301 - DELMAR; Paul ; et al.	2013-07-18
Blood Plasma Biomarkers For Bevacizumab Combination Therapies For Treatment Of Pancreatic Cancer App 20130108626 - DELMAR; Paul ; et al.	2013-05-02
Timp-1 As A Marker For Colorectal Cancer App 20100159479 - Rollinger; Wolfgang ; et al.	2010-06-24
Methods and compositions related to prediction of drug response App 20050100936 - Lutz, Verena ; et al.	2005-05-12
Use of check surfaces for identifying disturbing samples in a detection procedure Grant 6,815,217 - Karl , et al. November 9, 2	2004-11-09
Use Of Control Areas To Detect Interfering Samples In A Detection Method App 20030017616 - KARL, JOHANN ; et al.	2003-01-23
Method and device for metering liquids Grant 5,856,200 - Krause , et al. January 5, 1	1999-01-05
Apparatus for the detection of a fluid phase boundary in a transparent measuring tube and for the automatic exact metering of an amount of liquid Grant 5,463,228 - Krause October 31, 1	1995-10-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.